TPO and systemic sclerosis: In a separate study conducted by Posselt RT and colleagues, there was no statistically significant difference found among SSc patients with anti-TPO antibodies with hypothyroidism, those with anti-thyroid antibodies without hypothyroidism, and SSc patients without anti-thyroid antibodies when considering the mRRSS or the Medsger index [58].